FDA authorizes Pfizer booster shots for seniors and high-risk individuals
The Food and Drug Administration on Wednesday authorized booster doses of Pfizer's COVID-19 vaccine for Americans 65 and older and two other groups: younger people with underlying health conditions and those whose jobs put them at high risk of getting the virus.
Now, the Centers for Disease Control and Prevention must come up with its own recommendation on booster shots and when people should get them. A panel of CDC advisers convened on Wednesday to discuss the matter, and some suggested waiting a month and seeing what new evidence might come out about booster shots, The Associated Press reports.
Pfizer has released data compiled by the pharmaceutical company and the Israeli government, which suggests that boosters are beneficial for people 65 and older, but might not do as much for younger people, even those with underlying conditions.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"As we learn more about the safety and effectiveness of COVID-19 vaccines, including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed," Dr. Janet Woodcock, acting commissioner of the FDA, said in a statement.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
6 charming homes for the whimsical
Feature Featuring a 1924 factory-turned-loft in San Francisco and a home with custom murals in Yucca Valley
By The Week Staff Published
-
Big tech's big pivot
Opinion How Silicon Valley's corporate titans learned to love Trump
By Theunis Bates Published
-
Stacy Horn's 6 favorite works that explore the spectrum of evil
Feature The author recommends works by Kazuo Ishiguro, Anthony Doerr, and more
By The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published